piperidines has been researched along with Leiomyomatosis* in 2 studies
1 trial(s) available for piperidines and Leiomyomatosis
| Article | Year |
|---|---|
Remifentanil patient-controlled analgesia effect-site target-controlled infusion compared with morphine patient-controlled analgesia for treatment of acute pain after uterine artery embolization.
Post-procedural pain control after uterine artery embolization (UAE) of urethral leiomyomata remains a major problem.. This double-blind, randomized study tested the possibility to obtain a quicker onset of analgesia by using effect-compartment controlled remifentanil patient-controlled analgesia (remifentanil TCI-PCA) than by using i.v. morphine PCA. Both systems were connected to an i.v. catheter. Active drug or matching placebo administration was activated by a single push-button. Pain was assessed using a numerical rating scale (NRS) from 0 to 10.. NRS values were lower in the remifentanil group (with a possible difference from two to seven points on the scale) during the initial 4 h post-embolization. After the fourth hour, the NRS values were identical between the groups. No major respiratory or haemodynamic side-effect was observed.. Remifentanil PCA-TCI with a slow and progressive adapted algorithm without any associated premedication or co-medication is feasible in young healthy women undergoing UAE. Topics: Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Double-Blind Method; Drug Administration Schedule; Embolization, Therapeutic; Female; Humans; Infusions, Intravenous; Leiomyomatosis; Morphine; Pain; Pain Measurement; Piperidines; Remifentanil; Uterine Neoplasms; Uterus | 2011 |
1 other study(ies) available for piperidines and Leiomyomatosis
| Article | Year |
|---|---|
[Leiomyomatosis of the esophagus].
A rare case of dysphagia caused by leiomyomatosis of the esophagus is presented. Esophageal leiomyomatosis is triggered by diffuse proliferation of smooth muscle cells in the wall of the entire esophagus. Only 1.0% of all tumors of the esophagus are benign lesions; 0.4% of all esophageal neoplasms are leiomyomas. Only a few cases of leiomyomatosis-a special form of diffuse leiomyomas-have been described so far in the literature. Modern diagnostic imaging techniques such as CT and MR are described in esophageal leiomyomatosis. Topics: Anti-Ulcer Agents; Biopsy; Cisapride; Combined Modality Therapy; Deglutition Disorders; Esophageal Neoplasms; Esophagus; Follow-Up Studies; Humans; Leiomyomatosis; Magnetic Resonance Imaging; Male; Middle Aged; Nifedipine; Omeprazole; Pathology; Piperidines; Tomography, X-Ray Computed | 1994 |